当前位置： SCI文献检索 > BONE期刊下所有文献 > Three-dimensional confocal images of microdamage in cancellous bone.

Three-dimensional confocal images of microdamage in cancellous bone.

Abstract：

:The accumulation of microdamage in bone may contribute to loss of bone quality in osteoporosis, and the role of microdamage in the etiology of fatigue fractures is unknown. Microdamage created during testing, ex vivo, can increase the fragility of bone by decreasing the load necessary to cause fracture. Microdamage can also accumulate in vivo, but its influence on bone fragility is unknown. To date, stained microcracks are the only criteria to have been correlated with bone mechanics, leaving the influence of ultrastructural damage on bone fragility open for scrutiny. Staining en bloc has identified three morphological features in the tissue, discrete microcracks, cross-hatch staining, and diffuse staining. The relationship between these features and their identification as microdamage remains equivocal. The purpose of this study was to investigate the three-dimensional nature of microdamage in cancellous bone and also to describe stained microcracks, cross-hatch staining, and diffuse staining and to determine whether they all relate to microdamage in bone. Laser scanning confocal microscopy that provides improved spatial resolution over bright-field microscopy was used to visualize bone damage. It was found that crack surface density was highly correlated with crack density (r = 0.95, p < 0.0001), suggesting that the crack surface of preexisting cracks increases as new cracks are formed or submicroscopic cracks become visible under bright-field microscopy. Cross-hatch staining and diffuse staining included ultra-microcracks about 10 microm in length. The ultra-microcracks in cross-hatch staining were organized in bands and surrounded by diffuse staining. This study demonstrates that damage in bone occurs over a wide range and that discrete microcracks, cross-hatch staining, and diffuse staining are all indicative of bone damage. The diffuse staining still evident in association with the ultra-microcracks seen in cross-hatch staining and diffuse staining is probably due to damage at a still smaller scale than we have been able to investigate.

journal_name

Bone

journal_title

Bone

authors

Fazzalari NL,Forwood MR,Manthey BA,Smith K,Kolesik P

doi

10.1016/s8756-3282(98)00111-2

subject

Has Abstract

pub_date

1998-10-01 00:00:00

pages

373-8

issue

4

eissn

8756-3282

issn

1873-2763

pii

S8756-3282(98)00111-2

journal_volume

23

pub_type

杂志文章

相关文献

BONE文献大全
  • Plasma cyclic AMP response to calcitonin: a potential clinical marker of bone turnover.

    abstract：:A noninvasive marker of bone turnover would be useful in predicting which patients are at risk of rapid bone loss and in monitoring response to therapy. Calcitonin (CT)-induced hypocalcemia correlates with bone turnover but has not been a clinically useful test because changes in serum calcium are small, and test dura...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/8756-3282(85)90316-3

    authors： Minkoff JR,Grant BF,Marcus R

    更新日期：1985-01-01 00:00:00

  • Characterization of the effect of chronic administration of a calcium-sensing receptor antagonist, ronacaleret, on renal calcium excretion and serum calcium in postmenopausal women.

    abstract：:Ronacaleret is an orally-active calcium-sensing receptor (CaSR) antagonist that has the potential for therapeutic utility in the stimulation of PTH release, notably as a bone anabolic agent comparable to recombinant human PTH(1-34) (rhPTH(1-34)). A recent study has shown that, despite the ability to increase circulati...

    journal_title：Bone

    pub_type： 杂志文章,随机对照试验

    doi：10.1016/j.bone.2013.05.021

    authors： Caltabiano S,Dollery CT,Hossain M,Kurtinecz MT,Desjardins JP,Favus MJ,Kumar R,Fitzpatrick LA

    更新日期：2013-09-01 00:00:00

  • Prolonged alendronate treatment prevents the decline in serum TGF-β1 levels and reduces cortical bone strength in long-term estrogen deficiency rat model.

    abstract：INTRODUCTION:While the anti-resorptive effects of the bisphosphonates (BPs) are well documented, many questions remain about their mechanisms of action, particularly following long-term use. This study evaluated the effects of alendronate (Ale) treatment on TGF-β1 signaling in mesenchymal stem cells (MSCs) and osteocyt...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/j.bone.2012.10.017

    authors： Jia J,Yao W,Amugongo S,Shahnazari M,Dai W,Lay YA,Olvera D,Zimmermann EA,Ritchie RO,Li CS,Alliston T,Lane NE

    更新日期：2013-01-01 00:00:00

  • Effects of Src kinase inhibition by saracatinib (AZD0530) on bone turnover in advanced malignancy in a Phase I study.

    abstract：:Saracatinib (AZD0530) is an orally active once-daily Src kinase inhibitor which modulates key signaling pathways in cancer cells. In a Phase I study in patients with advanced solid malignancies resistant to standard treatment we assessed the effect of saracatinib on bone turnover. Fifty-one patients were randomized in...

    journal_title：Bone

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1016/j.bone.2011.12.017

    authors： Hannon RA,Finkelman RD,Clack G,Iacona RB,Rimmer M,Gossiel F,Baselga J,Eastell R

    更新日期：2012-04-01 00:00:00

  • Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formation.

    abstract：:Interleukin-1 (IL-1) has been shown to promote osteoclast (OC) differentiation, in addition to acting as a survival factor for mature osteoclasts. In this study, we investigate the expression of IL-1 during human osteoclast formation, taking advantage of a recently reported in vitro culture system that generates human...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/s8756-3282(99)00176-3

    authors： Haynes DR,Atkins GJ,Loric M,Crotti TN,Geary SM,Findlay DM

    更新日期：1999-09-01 00:00:00

  • Delayed bone age due to a dual effect of FGFR3 mutation in Achondroplasia.

    abstract：:Achondroplasia (ACH), the most common form of human dwarfism is caused by a mutation in the Fibroblast Growth Factor Receptor 3 (FGFR3) gene, resulting in constitutive activation of the receptor. Typical radiological features include shortening of the tubular bones and macrocephaly, due to disruption of endochondral o...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/j.bone.2010.07.020

    authors： Pannier S,Mugniery E,Jonquoy A,Benoist-Lasselin C,Odent T,Jais JP,Munnich A,Legeai-Mallet L

    更新日期：2010-11-01 00:00:00

  • Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism - The randomized, placebo-controlled EPATH trial.

    abstract：:Mineralocorticoid receptor (MR) antagonism may affect bone turnover via direct and indirect pathways involving parathyroid hormone, but randomized controlled trials are lacking. In a pre-specified analysis of the "Eplerenone in primary hyperparathyroidism" placebo-controlled, randomized trial (ISRCTN 33941607), effect...

    journal_title：Bone

    pub_type： 杂志文章,随机对照试验

    doi：10.1016/j.bone.2017.08.030

    authors： Verheyen N,Grübler MR,Meinitzer A,Trummer C,Schwetz V,Amrein K,Dimai HP,März W,Catena C,von Lewinski D,Voelkl J,Alesutan I,Fahrleitner-Pammer A,Brussee H,Pilz S,Tomaschitz A

    更新日期：2017-12-01 00:00:00

  • Osteocalcin, adipokines and their associations with glucose metabolism in type 1 diabetes.

    abstract：:To determine osteocalcin (OC) and adipokines in type 1 diabetes (T1D) and healthy controls, and to explore possible associations between glucose and bone metabolism, body composition and adipokines. Serum levels of total OC, undercarboxylated (UC-OC), leptin, adiponectin, and other parameters of glucose and bone metab...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/j.bone.2015.04.017

    authors： Neumann T,Lodes S,Kästner B,Franke S,Kiehntopf M,Lehmann T,Müller UA,Wolf G,Sämann A

    更新日期：2016-01-01 00:00:00

  • Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone.

    abstract：:Impaired osteoblast and osteocyte maturation contribute to mineralization defects and excess FGF23 expression in CKD bone. Vitamin D sterols decrease osteoid accumulation and increase FGF23 expression; these agents also increase osteoblast maturation in vitro but a link between changes in bone cell maturation, bone mi...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/j.bone.2019.07.026

    authors： Pereira RC,Salusky IB,Bowen RE,Freymiller EG,Wesseling-Perry K

    更新日期：2019-10-01 00:00:00

  • Subcloning of three osteoblastic cell lines with distinct differentiation phenotypes from the mouse osteoblastic cell line KS-4.

    abstract：:Three distinct osteoblastic cell lines (KS418, KS460, and KS483) were subcloned from the mouse osteoblastic KS-4 cells, which possessed the abilities not only to differentiate into mature osteoblasts, but also to support osteoclast differentiation in coculture with spleen cells. The order of the magnitude of the basal...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/s8756-3282(96)00255-4

    authors： Yamashita T,Ishii H,Shimoda K,Sampath TK,Katagiri T,Wada M,Osawa T,Suda T

    更新日期：1996-11-01 00:00:00

  • Exercise-induced changes in the cortical bone of growing mice are bone- and gender-specific.

    abstract：:Fracture risk and mechanical competence of bone are functions of bone mass and tissue quality, which in turn are dependent on the bone's mechanical environment. Male mice have a greater response to non-weight-bearing exercise than females, resulting in larger, stronger bones compared with control animals. The aim of t...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/j.bone.2006.12.002

    authors： Wallace JM,Rajachar RM,Allen MR,Bloomfield SA,Robey PG,Young MF,Kohn DH

    更新日期：2007-04-01 00:00:00

  • Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia.

    abstract：:Hypophosphatasia (HPP) is the inborn-error-of-metabolism caused by loss-of-function mutation(s) of the ALPL gene that encodes the tissue-nonspecific isoenzyme of alkaline phosphatase (TNSALP). TNSALP in healthy individuals is on cell surfaces richly in bone, liver, and kidney. Thus, TNSALP natural substrates accumulat...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/j.bone.2020.115300

    authors： Whyte MP,Zhang F,Wenkert D,Mumm S,Berndt TJ,Kumar R

    更新日期：2020-05-01 00:00:00

  • Combination therapy with eldecalcitol and alendronate has therapeutic advantages over monotherapy by improving bone strength.

    abstract：:Eldecalcitol (ED-71), a 2β-hydroxypropyloxy derivative of 1α,25(OH)(2)D(3), inhibits bone resorption more potently than does alfacalcidol while maintaining osteoblastic function in an estrogen-deficient, high-turnover osteoporosis rat model. Alendronate (ALN) has been reported to increase bone mass by suppressing bone...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/j.bone.2012.02.005

    authors： Sakai S,Endo K,Takeda S,Mihara M,Shiraishi A

    更新日期：2012-05-01 00:00:00

  • A review of current murine models of multiple myeloma used to assess the efficacy of therapeutic agents on tumour growth and bone disease.

    abstract：:Pre-clinical in vivo models of multiple myeloma are essential tools for investigating the pathophysiology of multiple myeloma and for testing new therapeutic agents and strategies prior to their potential use in clinical trials. Over the last five decades, several different types of murine models of multiple myeloma h...

    journal_title：Bone

    pub_type： 杂志文章,评审

    doi：10.1016/j.bone.2015.04.004

    authors： Paton-Hough J,Chantry AD,Lawson MA

    更新日期：2015-08-01 00:00:00

  • Changes in chemical composition of cortical bone associated with bone fragility in rat model with chronic kidney disease.

    abstract：:Bone fragility is a complication of chronic kidney disease (CKD). Patients on dialysis have higher risk of fracture than the general population, but the reason remains obscure. Bone strength is determined by bone mass and bone quality. Although factors affecting bone quality include microarchitecture, remodeling activ...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/j.bone.2011.03.672

    authors： Iwasaki Y,Kazama JJ,Yamato H,Fukagawa M

    更新日期：2011-06-01 00:00:00

  • Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model.

    abstract：:Both bone density and quality are important determinants of bone strength. Bone quality is prescribed by matrix characteristic including collagen cross-linking and bone structural characteristics and is important in reinforcement of bone strength. We investigated the effects of alfacalcidol (ALF), a prodrug of calcitr...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/j.bone.2009.12.008

    authors： Saito M,Shiraishi A,Ito M,Sakai S,Hayakawa N,Mihara M,Marumo K

    更新日期：2010-04-01 00:00:00

  • Mechanisms of palmitate-induced lipotoxicity in osteocytes.

    abstract：BACKGROUND:Lipotoxicity is defined as cellular toxicity observed in the presence of an abnormal accumulation of fat and adipocyte-derived factors in non-fat tissues. Palmitic acid (PA), an abundant fatty acid in the bone marrow and particularly in osteoporotic bones, affects osteoblastogenesis and osteoblast function, ...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/j.bone.2019.06.016

    authors： Al Saedi A,Bermeo S,Plotkin L,Myers DE,Duque G

    更新日期：2019-10-01 00:00:00

  • Vitamin D receptor polymorphism, bone mineral density, and osteoporotic vertebral fracture: studies in a UK population.

    abstract：:Bone mineral density is under strong genetic control and polymorphisms of the vitamin D receptor (VDR) have been suggested to account for some of the genetic variation in bone mass. However, the relationship between VDR polymorphisms and bone density is controversial and has not been confirmed by all workers. Since th...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/8756-3282(95)00483-1

    authors： Houston LA,Grant SF,Reid DM,Ralston SH

    更新日期：1996-03-01 00:00:00

  • Proteomic studies of bone and skeletal health outcomes.

    abstract：:Proteins are an essential part of essentially all biological processes, and there is enormous variation in protein forms and concentrations that is not reflected in DNA or RNA. Recently there have been rapid advances in the ability to measure protein sequence, modification and concentration, particularly with methods ...

    journal_title：Bone

    pub_type： 杂志文章,评审

    doi：10.1016/j.bone.2019.03.032

    authors： Nielson CM,Jacobs JM,Orwoll ES

    更新日期：2019-09-01 00:00:00

  • Different effects of age, adiposity and physical activity on the risk of ankle, wrist and hip fractures in postmenopausal women.

    abstract：:While increasing age, decreasing body mass index (BMI), and physical inactivity are known to increase hip fracture risk, whether these factors have similar effects on other common fractures is not well established. We used prospectively-collected data from a large cohort to examine the role of these factors on the ris...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/j.bone.2012.03.014

    authors： Armstrong ME,Cairns BJ,Banks E,Green J,Reeves GK,Beral V,Million Women Study Collaborators.

    更新日期：2012-06-01 00:00:00

  • Whole-exome sequencing reveals a heterozygous LRP5 mutation in a 6-year-old boy with vertebral compression fractures and low trabecular bone density.

    abstract：:Juvenile osteoporosis (JO) is characterized by bone fragility during development, low bone mass and absence of extraskeletal features. Heterozygous loss-of-function mutations in LRP5 have been found in a few patients, but bone tissue and bone material abnormalities associated with such mutations have not been determin...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/j.bone.2013.07.020

    authors： Fahiminiya S,Majewski J,Roughley P,Roschger P,Klaushofer K,Rauch F

    更新日期：2013-11-01 00:00:00

  • Glucose metabolism in bone.

    abstract：:The adult human skeleton is a multifunctional organ undergoing constant remodeling through the opposing activities of the bone-resorbing osteoclast and the bone-forming osteoblast. The exquisite balance between bone resorption and bone formation is responsible for bone homeostasis in healthy adults. However, evidence ...

    journal_title：Bone

    pub_type： 杂志文章,评审

    doi：10.1016/j.bone.2017.08.008

    authors： Karner CM,Long F

    更新日期：2018-10-01 00:00:00

  • Common herbs, essential oils, and monoterpenes potently modulate bone metabolism.

    abstract：:During our survey of herbs looking for activity on bone metabolism, we found that the dried leaves of sage strongly inhibit bone resorption. Therefore, we investigated several common herbs rich in essential oils (sage, rosemary, and thyme) and essential oils extracted from these herbs and other plants (oils of sage, r...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/s8756-3282(03)00027-9

    authors： Mühlbauer RC,Lozano A,Palacio S,Reinli A,Felix R

    更新日期：2003-04-01 00:00:00

  • Bone mass and endocrine adaptations to training in spinal cord injured individuals.

    abstract：:To investigate whether exercise training can produce increases in bone mass in spinal cord-injured (SCI) individuals with established disuse osteopenia, nine subjects (age 28.2 years, time since injury 6.0 years, level of injury C5-T7) were recruited for a 9-month training program using functional electrical stimulati...

    journal_title：Bone

    pub_type： 临床试验,杂志文章

    doi：10.1016/8756-3282(96)00109-3

    authors： Bloomfield SA,Mysiw WJ,Jackson RD

    更新日期：1996-07-01 00:00:00

  • RUNX2 alleles associated with BMD in Scottish women; interaction of RUNX2 alleles with menopausal status and body mass index.

    abstract：:Bone mineral density (BMD) is influenced by both environmental and genetic factors. We previously reported the association of the RUNX2 A allele with increased bone mineral density (BMD) and protection against a common form of osteoporotic fracture within a Geelong population. We genotyped 991 women from a Scottish co...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/j.bone.2004.02.004

    authors： Vaughan T,Reid DM,Morrison NA,Ralston SH

    更新日期：2004-06-01 00:00:00

  • Androgen prevents hypogonadal bone loss via inhibition of resorption mediated by mature osteoblasts/osteocytes.

    abstract：:Androgen receptor (AR) is expressed throughout the osteoblast lineage. Two different AR transgenic families (AR2.3-tg and AR3.6-tg mice) demonstrating overlapping and distinct expression profiles were employed to assess the effects of enhanced androgen sensitivity to ameliorate hypogonadal loss. Two different paradigm...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/j.bone.2012.08.111

    authors： Wiren KM,Zhang XW,Olson DA,Turner RT,Iwaniec UT

    更新日期：2012-11-01 00:00:00

  • Characterization of damage mechanisms associated with reference point indentation in human bone.

    abstract：:Measurement of bone mineral density (BMD) is the clinical gold standard in cases of compromised skeletal integrity, such as with osteoporosis. While BMD is a useful measurement to index skeletal health, it is also limited since it cannot directly assess any mechanical properties. The ability to directly assess mechani...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/j.bone.2015.01.019

    authors： Beutel BG,Kennedy OD

    更新日期：2015-06-01 00:00:00

  • Scoliosis in osteogenesis imperfecta caused by COL1A1/COL1A2 mutations - genotype-phenotype correlations and effect of bisphosphonate treatment.

    abstract：:Bisphosphonates are widely used to treat children with osteogenesis imperfecta (OI), a bone fragility disorder that is most often caused by mutations in COL1A1 or COL1A2. However, it is unclear whether this treatment decreases the risk of developing scoliosis. We retrospectively evaluated spine radiographs and charts ...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/j.bone.2016.02.018

    authors： Sato A,Ouellet J,Muneta T,Glorieux FH,Rauch F

    更新日期：2016-05-01 00:00:00

  • GIT1 is critical for formation of the CD31hiEmcnhi vessel subtype in coupling osteogenesis with angiogenesis via modulating preosteoclasts secretion of PDGF-BB.

    abstract：:G protein-coupled receptor kinase 2 interacting protein-1 (GIT1) is a scaffold protein that plays a vital role in bone modeling and remodeling during osteogenesis coupled with angiogenesis. Recent studies have shown that a specialized subset of vascular endothelium strongly positive for CD31 and Endomucin (CD31hiEmcnh...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/j.bone.2019.03.006

    authors： Xu T,Luo Y,Kong F,Lv B,Zhao S,Chen J,Liu W,Cheng L,Zhou Z,Zhou Z,Huang Y,Li L,Zhao X,Qian D,Fan J,Yin G

    更新日期：2019-05-01 00:00:00

  • Intake of vitamin K1 and K2 and risk of hip fractures: The Hordaland Health Study.

    abstract：BACKGROUND:Evidence of the effect of vitamin K on bone health is conflicting. The aim was to investigate the association between intake of vitamins K1 and K2 and subsequent risk of hip fracture in a general population sample, as well as potential effect modification by apolipoprotein E gene (APOE) status by presence of...

    journal_title：Bone

    pub_type： 杂志文章

    doi：10.1016/j.bone.2011.07.035

    authors： Apalset EM,Gjesdal CG,Eide GE,Tell GS

    更新日期：2011-11-01 00:00:00